New study highlights massive prescription price hikes
Derma-Smoothe oil is a topical treatment for eczema that cost $46 in 2009. This year, its retail drugstore price hit $323.
Nov 26, 2015
1
33
Derma-Smoothe oil is a topical treatment for eczema that cost $46 in 2009. This year, its retail drugstore price hit $323.
Nov 26, 2015
1
33
Despite legal and ethical requirements, information on clinical trials for drugs approved by the U.S. Food and Drug Administration (FDA) varied widely among some of the world's largest drug companies, according to a new study ...
Nov 12, 2015
0
36
Last week Turing Pharmaceuticals, a startup run by a former hedge-fund manager, raised the price of Daraprim—the standard treatment for toxoplasmosis—from $13.50 to $750 a tablet soon after acquiring the drug from another ...
Oct 2, 2015
2
19
Soaring prices for everything from cancer treatments to hepatitis C pills that cost more than $100,000 have sparked outcry in the United States in recent years, but calls for change have gone largely unheeded.
Sep 23, 2015
0
34
Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...
Sep 1, 2015
0
3
Early research on a new malaria drug shows potential for a single dose treatment of the disease. The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials ...
Aug 11, 2015
0
33
Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...
Jul 2, 2015
0
9
US experts urged regulators Wednesday to approve a second new anti-cholesterol drug, a day after recommending they bring to market the first in a new class of medications to lower the risk of heart attack.
Jun 10, 2015
0
11
Fixed-dose drug combinations (FDCs) which have not received central regulatory approval are sold in substantial numbers in India—despite concerns over the safety and efficacy of these combinations—according to new research ...
May 12, 2015
0
6
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10